Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes
Public ClinicalTrials.gov record NCT05506423. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Observational Registry Study of Safety and Effectiveness Outcomes Through 24 Months Postoperatively Following CycloPen™ Micro-Interventional Cyclodialysis System Procedures in Patients With Open Angle Glaucoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This observational study will enroll adults with open angle glaucoma (OAG) who had surgery to reduce intraocular pressure (IOP) using the CycloPen Micro-Interventional System. Consenting participants will be followed for 24 months after their surgery. Data regarding IOP, use of glaucoma medications, and any side effects related to the surgery will be collected from participants' preoperative examination, their surgery, and postoperative examinations.
Study identification
- NCT ID
- NCT05506423
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 17, 2022 (Actual)
- Primary completion
- Dec 2026 (Estimated)
- Completion
- Dec 2027 (Estimated)
- Last update posted
- Jul 22, 2026
2022 – 2027
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Visionary Eye Institute | Newport Beach | California | 92663 | — |
| Tyson Eye | Cape Coral | Florida | 33904 | — |
| Central Florida Eye Specialists | DeLand | Florida | 32720 | — |
| Eye Associates of Ft. Myers | Fort Myers | Florida | 33912 | — |
| Omni Eye Services | Atlanta | Georgia | 30342 | — |
| Eye Doctors of Washington | Chevy Chase | Maryland | 20815 | — |
| Visionary Eye Doctors | Rockville | Maryland | 20852 | — |
| Center for Sight | Las Vegas | Nevada | 89145 | — |
| Wilton Center for Advanced Eyecare | New Brunswick | New Jersey | 07728 | — |
| North Manhattan Eye Center | New York | New York | 10034 | — |
| Buffalo Ophthalmology | Williamsville | New York | 14221 | — |
| James S Lewis, MD | Fort Washington | Pennsylvania | 19034 | — |
| Eye Centers of Tennessee | Crossville | Tennessee | 38555 | — |
| Ophthalmology Associates | Fort Worth | Texas | 76102 | — |
| John Moran Eye Center - U of Utah | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05506423, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 22, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05506423 live on ClinicalTrials.gov.